Bottom line
What is CPSHX's expense ratio?
CPSHX's expense ratio is 2.55%, or about $255 a year on every $10,000 invested. That is more expensive than 86% of alternatives funds we track (median 1.54%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Jan 27, 2026
CPSHX fee table
| Net expense ratio | 2.55% |
|---|---|
| Gross expense ratio | 3.07% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.76% |
| Acquired fund fees | 0.31% |
| Fee waiver / reimbursement | -0.52% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | -1% |
Source: Fund prospectus fee table, filed Jan 27, 2026
What CPSHX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CPSHX | $258 | $899 | $1,566 | $3,347 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.55% expense ratio costs roughly $123,600 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).